EXC.NASDAQExelon CORP

Form 4: Exelon Director Matthew Rogers Reports Acquisition of Deferred Stock Units

Sentiment:

SEC Form 4 Filing


Director Matthew C Rogers reports acquiring 1,131 shares of Exelon Corp. deferred stock units at $36.48 per share on March 31, 2024, bringing his total to 4,010 shares.

Summary

  • On March 31, 2024, Matthew C Rogers, a director of Exelon Corp, acquired 1,131 shares of common stock in the form of deferred stock units.
  • The price per share was $36.48.
  • This acquisition was made under the Exelon Corp. Directors Deferred Stock Unit Plan.
  • Following the transaction, Rogers beneficially owns a total of 4,010 shares of common stock through the deferred stock unit plan, which includes 30 additional shares acquired through automatic dividend reinvestment.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't convey any explicit positive or negative sentiment about the company's performance or prospects.

Positives

  • The acquisition of shares by a director may signal confidence in the company's future performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

  • The transaction has a minimal direct impact on stakeholders, as it is a routine acquisition of deferred stock units by a director.

Key Dates

DateDescription
03/31/2024Date of transaction: Acquisition of 1,131 shares of common stock-deferred stock units.
04/02/2024Date of signature by attorney-in-fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.